Differential diagnosis of human ascites: inhibitors of the contact system and total proteins.
To assess their accuracies as markers for malignancy, we assayed alpha 2-macroglobulin, C1-inhibitor, alpha 1-protease inhibitor, and total proteins in ascites and plasma from patients with gastrointestinal cancer (n = 15) and non-malignant liver disease (n = 13), using functional and immunologic assays. For all inhibitors and total proteins determined in ascites, the values in the cancer group were significantly higher than the corresponding values in the group with non-malignant liver disease. The diagnostic accuracy for differentiating malignancy-related from non-malignant ascites was 93% for a alpha 1-protease inhibitor value > or = 50% of the pool plasma value and 90% for alpha 2-macroglobulin > or = 16%, C1-inhibitor > or = 40% (all functional assays), and total proteins > or = 20 g/l (biuret). In conclusion, functional assays for alpha 2-macroglobulin, C1-inhibitor, and alpha 1-protease inhibitor and determination of total proteins in ascites appeared to be very informative tests for the differential diagnosis of ascites. The test for alpha 1-protease inhibitor gave higher specificity (92% versus 77%) and likelihood ratio for a positive test (12 versus 4) compared with the other tests.
Buø
L
L
Dept. of Medicine A, Rikshopsitalet, National Hospital, Oslo, Norway.
Karlsrud
T S
TS
Dyrhaug
G
G
Jacobsen
M B
MB
Bell
H
H
Johansen
H T
HT
Aasen
A O
AO
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001201:Ascites / Q000175:diagnosis* / Q000209:etiology; D001202:Ascitic Fluid / Q000737:chemistry*; D014408:Biomarkers, Tumor / Q000032:analysis*; D003174:Complement C1 Inactivator Proteins / Q000032:analysis; D003937:Diagnosis, Differential; D005260:Female; D005770:Gastrointestinal Neoplasms / Q000175:diagnosis*; D006801:Humans; D008107:Liver Diseases / Q000175:diagnosis*; D008297:Male; D008875:Middle Aged; D011480:Protease Inhibitors / Q000032:analysis*; D011506:Proteins / Q000032:analysis*; D000511:alpha-Macroglobulins / Q000032:analysis
D014408:Biomarkers, Tumor; D003174:Complement C1 Inactivator Proteins; D011480:Protease Inhibitors; D011506:Proteins; D000511:alpha-Macroglobulins